These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6631718)

  • 21. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
    Lindner W; Rath M; Stoschitzky K; Semmelrock HJ
    Chirality; 1989; 1(1):10-3. PubMed ID: 2642031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    Nelson WL; Bartels MJ
    Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma.
    Silber B; Riegelman S
    J Pharmacol Exp Ther; 1980 Dec; 215(3):643-8. PubMed ID: 7441523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereochemistry of tissue distribution of racemic propranolol in the dog.
    Walle UK; Thibodeaux H; Privitera PJ; Walle T
    Chirality; 1989; 1(3):192-6. PubMed ID: 2642048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative account of propranolol metabolism in urine of normal man.
    Walle T; Walle UK; Olanoff LS
    Drug Metab Dispos; 1985; 13(2):204-9. PubMed ID: 2859169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
    Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
    Honma S; Ito T; Matsuki Y
    Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
    [No Abstract]   [Full Text] [Related]  

  • 31. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of glucuronidation of propranolol following oral administration in humans.
    Midha KK; Roscoe RM; Wilson TW; Cooper JK; Loo JC; Ho-Ngoc A; McGilveray IJ
    Biopharm Drug Dispos; 1983; 4(4):331-8. PubMed ID: 6661512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselectivity and interaction between the glucuronidation of S-(-)- and R-(+)-propranolol in rat hepatic microsomes pretreated with different inducers.
    Luan LJ; Shao Q; Zeng S
    Pharmazie; 2005 Mar; 60(3):221-4. PubMed ID: 15801678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1982 Sep; 222(3):589-94. PubMed ID: 7108766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.
    Adebowale A; Du J; Liang Z; Leslie JL; Eddington ND
    Biopharm Drug Dispos; 2002 Sep; 23(6):217-25. PubMed ID: 12214321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The absence of stereoselectivity in propranolol uptake by the lungs].
    Shvachko EV; Rumiantsev DO; Piotrovskiĭ VK; Mazaev VP
    Eksp Klin Farmakol; 1992; 55(6):40-3. PubMed ID: 1305875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.